ABAna Gabriela Finke Barriga

Ana Gabriela Finke Barriga

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ana Gabriela Finke Barriga has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Extravasation of TPN into the pleural space, a rare complication of central venous catheter placement: a case report

    by Gabriel A. Molina, Rommel Ojeda, Galo E. Jimenez, Andres V. Ayala, Karina Naranjo, Anita G. Finke

    Background: Complications associated with central venous catheters are well documented in the literature, most of which relate to catheter placement or infections. Nonetheless, on rare occasions, the catheter can erode the arterial wall, allowing medication, fluids, or even total parenteral nutrition to pass into the pleural space. Case presentation: We present the case of a 68-year-old male who was critically ill in the intensive care unit and required total parenteral nutrition. A central venous catheter was placed, and the patient’s condition improved. While in the intensive care unit, it became necessary to change the central line, and a new catheter was placed. Subsequently, he experienced respiratory distress and impaired oxygenation, with a significant pleural effusion. When the chest tube was placed, a milky-white fluid was detected, and subsequent tests revealed it to be an effusion of total parenteral nutrition. Following this event, the catheter was immediately changed, and with subsequent treatment, the patient recovered completely. Conclusion: Identification and management of central line complications are essential in patients with vascular access. These rare complications must always be considered in the differential diagnosis and recognized early to avoid potentially dangerous outcomes.

  • Open Access

    Clinical and Epidemiological Profile of Atrial Fibrillation in a High-Altitude Tertiary-Care Setting

    by Vladimir Ernesto Ullauri-Solórzano, René Antonio Vicuña Mariño, Diego Ricardo Egas Proaño, Diana Moreira-Vera, Henrry Oswaldo Jaramillo Prado, Ana Gabriela Finke Barriga, Gabriela Tatiana León Molina, Juan José Paz Y Miño, Ronald Alfredo Cevallos Macías, Jorge Vasconez-Gonzalez, et al.

    Background and Objectives: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and a major cause of stroke, heart failure, and death. Evidence on AF in Latin American and Andean tertiary-care settings remains limited. The objective was to describe the demographic and clinical profile, documented thromboembolic and bleeding risk, in-hospital management, and outcomes of adults with AF treated at a tertiary hospital located at 2850 m above sea level. Materials and Methods: We retrospectively reviewed unique adult patient records from January 2021 through December 2023 identified by ICD-10 code I48 and explicit clinician documentation of AF. Independent electrocardiographic adjudication was not performed. Demographics, comorbidities, chart-recorded AF category, risk scores, echocardiographic findings, in-hospital treatments, and outcomes were summarized descriptively. Results: Among 238 patients, mean age was 77.9 ± 13.3 years, 55.0% were male, and 97.1% were recorded as mestizo. Hypertension (58.0%) and heart failure (22.7%) were the most frequent comorbidities. CHA2DS2-VASc and HAS-BLED scores were documented for 199 patients (83.6%); their respective means were 3.3 ± 1.4 and 2.3 ± 1.1. Any anticoagulant was administered during hospitalization to 195 patients (81.9%), but previous and discharge therapy, indications, contraindications, dosing, and temporary interruptions were not consistently available. Five patients died in hospital (2.1%). Secondary exploratory comparisons by survival status were hypothesis-generating, and none remained significant after false-discovery-rate correction. Conclusions: This cohort describes an older, comorbid population treated at a hospital situated at high altitude. The study does not establish an altitude-related AF phenotype, the appropriateness of chronic anticoagulation, or prognostic factors for mortality. Prospective multicentre studies with adjudicated AF, individual altitude exposure, oxygenation and haematologic measures, and longitudinal treatment data are warranted.

  • Open Access

    Retrospective Analysis of the Epidemiological and Clinical Characteristics of Acute Coronary Syndrome in a Tertiary Hospital Located at High Altitude

    by Vladimir E. Ullauri-Solórzano, Christian Humberto Fierro Renoy, Juan Carlos Gaibor Barba, Diana Moreira-Vera, Henrry Oswaldo Jaramillo Prado, Ana Gabriela Finke Barriga, Víctor Arias Adriano, Francisco Xavier Castro Vega, Ana Cristina Chiliquinga, Kateherine Fonte Melendres, et al.

    Background: Cardiovascular diseases (CVDs) are the leading global cause of death, responsible for 17.9 million deaths annually (32%) as of 2019. Acute coronary syndrome (ACS) significantly contributes to this burden, particularly in low- and middle-income countries. In Latin America, ACS accounts for 35% of deaths. In Ecuador, 36,058 deaths were reported between 2019 and 2021, underscoring its significant public health impact. Objectives: This study aimed to determine the epidemiological, clinical, and hospital management characteristics of ACS patients admitted to the Metropolitan Hospital of Quito, located at high altitude, from January 2021 to October 2023. Methodology: A retrospective observational study analyzed anonymized medical records of 133 ACS patients treated at a tertiary care hospital in Quito. Results: Among 133 ACS patients, 72.9% were male, with a mean age of 68.9 ± 13.9 years. Overweight was prevalent, with a mean BMI of 26.6 ± 3.0 kg/m2. Hypertension (51.9%) and type 2 diabetes mellitus (26.3%) were common comorbidities. ST-segment elevation myocardial infarction (STEMI) was the most frequent ACS type (48.9%), followed by non-ST-segment elevation myocardial infarction (NSTEMI) (33.8%). Most patients (72.2%) underwent stent placement. Mortality was low (2.3%) and significantly associated with the presence of immunologic diseases (p = 0.015), TIMI risk score Grade IV (p = 0.009), and cardiac arrest on admission (p < 0.001). Conclusions: This study provides critical insights into the epidemiology and management of ACS in a high-altitude urban setting, emphasizing the importance of timely diagnosis and evidence-based therapies in improving patient outcomes.


  • Open Access

    Progressive dysphagia from an esophageal liposarcoma, a complex problem in a challenging setting

    by Santiago A Endara, Gerardo A Dávalos, Ana G Finke, Veronica Ayala, Nelson A Montalvo, Santiago Munoz-Palomeque, Gabriel A Molina

    Esophageal lipomatous tumors are extremely rare, and due to their nonspecific clinical manifestations, distinguishing them is nearly impossible without the aid of histopathology, immunohistochemistry, and molecular analysis. Complete resection with clear margins is the treatment of choice to avert metastasis, improve prognosis, and prevent complex complications due to the polyp growth and location. We present the case of a 70-year-old male who presented in 2023 with dysphagia due to an esophageal polyp; surgery was recommended. However, he did not accept any treatment due to fear. One year later, and since his symptoms worsened, he finally decided to undergo endoscopic treatment at another medical institution. However, during that procedure, he suffered severe asphyxia, which caused a cardiopulmonary arrest. Once he partially recovered and because he continued with dysphagia, surgery was completed, and the polyp was removed. The final diagnosis was esophageal liposarcoma.